The most recent addition to our treatment armamentarium for presbyopia is the use of pharmaceutical agents that induce pupil miosis which results in an extended depth of focus to improve near vision. Contact lenses have been a mainstay in presbyopia management. This course will explore how new pharmaceutical options can optimize outcomes in the treatment of presbyopia when used in combination with a variety of contact lens modalities.   

Speaker: Barry Eiden, O.D.

Date: Thursday, February 19, 2026

Time: 5:30 PM - 6:30 PM Pacific Time

Location: Virtual

Moderator: Dr. Jennifer Stewart

Cost: Free!

COPE ID: 102731-PH

Category: Pharmacology

Thank you to Lenz Therapeutics for exhibiting at this event.

This event is undergoing COPE approval for 1 hour of Pharmacology CE credit.